Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading up 75 points (+0.4%) at 17,054 as of Thursday, Aug 21, 2014, 10:36 a.m. ET. During this time, 60.2 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 302.5 million. The NYSE advances/declines ratio sits at 1,551 issues advancing vs. 1,304 declining with 211 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Friday, August 22, 2014 is the ex-dividend date for Dow component Johnson & Johnson (NYSE: JNJ). Owners of shares as of market close today will be eligible for a dividend of 70 cents per share. At a price of $104.24 as of 10:36 a.m. ET, the dividend yield is 2.7% compared to the average Dow component yield of 2.6%.

The average volume for Johnson & Johnson has been 6.2 million shares per day over the past 30 days. Johnson & Johnson has a market cap of $290.38 billion and is part of the health care sector and drugs industry. Shares are up 12.7% year-to-date as of Wednesday's close.

Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The company has a P/E ratio of 19, equal to the average drugs industry P/E ratio.
  • Practice your dividend trading strategies and win cash in our stock game.

TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, growth in earnings per share and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Asia Markets Fall on Latest Tariff Threats From Trump

Asia Markets Fall on Latest Tariff Threats From Trump

Google Invests in JD.com; Comcast-Disney Battle Nears Head -- ICYMI

Google Invests in JD.com; Comcast-Disney Battle Nears Head -- ICYMI

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Dow Drops Over 100 Points on Trade War Worries

Dow Drops Over 100 Points on Trade War Worries